Summary:

Summary:

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

Updated 6/27/22 Summary The International Liver Congress (ILC) 2022 is taking place from June 22 - 26 in-person at ExCeL in London and...

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...